Ocugen Inc. (OCGN)
Ocugen Statistics
Share Statistics
Ocugen has 292.01M shares outstanding. The number of shares has increased by 13.47% in one year.
| Shares Outstanding | 292.01M |
| Shares Change (YoY) | 13.47% |
| Shares Change (QoQ) | 0.24% |
| Owned by Institutions (%) | 24.63% |
| Shares Floating | 286.75M |
| Failed to Deliver (FTD) Shares | 89.53K |
| FTD / Avg. Volume | 2.21% |
Short Selling Information
The latest short interest is 56.11M, so 19.26% of the outstanding shares have been sold short.
| Short Interest | 56.11M |
| Short % of Shares Out | 19.26% |
| Short % of Float | 19.61% |
| Short Ratio (days to cover) | 8.85 |
Valuation Ratios
The PE ratio is -4.04 and the forward PE ratio is -2.67. Ocugen's PEG ratio is 0.17.
| PE Ratio | -4.04 |
| Forward PE | -2.67 |
| PS Ratio | 53.8 |
| Forward PS | 0.3 |
| PB Ratio | 7.36 |
| P/FCF Ratio | -4.79 |
| PEG Ratio | 0.17 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ocugen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.86 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -0.09 |
| Debt / FCF | -0.11 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $42.68K |
| Profits Per Employee | $-568.99K |
| Employee Count | 95 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -54.3% in the last 52 weeks. The beta is 3.89, so Ocugen's price volatility has been higher than the market average.
| Beta | 3.89 |
| 52-Week Price Change | -54.3% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 53.4 |
| Average Volume (20 Days) | 4.06M |
Income Statement
In the last 12 months, Ocugen had revenue of 4.05M and earned -54.05M in profits. Earnings per share was -0.2.
| Revenue | 4.05M |
| Gross Profit | 4.05M |
| Operating Income | -54.76M |
| Net Income | -54.05M |
| EBITDA | -54.76M |
| EBIT | -54.76M |
| Earnings Per Share (EPS) | -0.2 |
Balance Sheet
The company has 58.51M in cash and 5.16M in debt, giving a net cash position of 53.36M.
| Cash & Cash Equivalents | 58.51M |
| Total Debt | 5.16M |
| Net Cash | 53.36M |
| Retained Earnings | -340.22M |
| Total Assets | 82.44M |
| Working Capital | 40.09M |
Cash Flow
In the last 12 months, operating cash flow was -42.14M and capital expenditures -3.38M, giving a free cash flow of -45.53M.
| Operating Cash Flow | -42.14M |
| Capital Expenditures | -3.38M |
| Free Cash Flow | -45.53M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 100%, with operating and profit margins of -1350.36% and -1333.02%.
| Gross Margin | 100% |
| Operating Margin | -1350.36% |
| Pretax Margin | -1333.02% |
| Profit Margin | -1333.02% |
| EBITDA Margin | -1350.36% |
| EBIT Margin | -1350.36% |
| FCF Margin | -1122.74% |
Dividends & Yields
OCGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for OCGN is $7, which is 914.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 914.5% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Sep 30, 2019. It was a backward split with a ratio of 1:60.
| Last Split Date | Sep 30, 2019 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -5.12 |
| Piotroski F-Score | 3 |